# Calporta Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/calporta-therapeutics

- Industry: Pharmaceuticals
- Headquarters: US
- Total disclosed funding: $3M
- Latest round: Series A (Jun 15, 2015)
- Investors on record: 2

## About

Founded in 2015 and based in California, US, Calporta Therapeutics, Inc.  operates as a developer of small molecule agonists of TRPML1 for the treatment of Niemann-Pick C Disease (NPC) and other lysosomal storage diseases.

## Funding rounds

- Series A, Jun 15, 2015, $3M — Avalon Ventures, GlaxoSmithKline

## Investors

- Avalon Ventures (https://capitalatlas.ai/funds/avalon-ventures) — Series A
- GlaxoSmithKline — Series A